Drugs / EC90 (KLH-FITC)
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00329368 | Sep 2005 → Dec 2007 | cancer | Endocyte | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EC90 (KLH-FITC) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00329368 ↗ |
| Modality | Vaccine | “EC90 vaccine” NCT00329368 ↗ |
| Route | Subcutaneous | “administered subcutaneously” NCT00329368 ↗ |